We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Valneva Announces $42 Million IXIARO® Supply Contract with US Government

News   Mar 16, 2016

 
Valneva Announces $42 Million IXIARO® Supply Contract with US Government
 
 
Advertisement
 

RELATED ARTICLES

Unique Melanoma Markers Could Pave the Way for Therapeutic Vaccines

News

Researchers have discovered new markers, known as HLA-associated peptides, that are uniquely present on melanoma tumors. This finding could pave the way for therapeutic vaccines to be developed against melanoma.

READ MORE

Clinical Trial Will Test Inhalation of Two Coronavirus Vaccines Currently in Development

News

Imperial researchers are set to begin trials to assess the safety and effectiveness of two of the UK’s coronavirus vaccines in development, when inhaled into the lungs.

READ MORE

3 in 10 Americans Unwilling To Get a COVID-19 Vaccine, Survey Finds

News

Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine when one becomes available, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE